Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
SYRE —
SPYRE THERAPEUTICS INC
CUSIP: 00773J202 · Held by 1 superinvestor · Combined value: $2,909,219
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $2,909,219 | 88,804 | NEW BUY | +88,804 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | NEW BUY | +88,804 | New |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | SOLD | -30,936 | Exit |
Who Owns SYRE? Superinvestor Holdings
SPYRE THERAPEUTICS INC is held by 1 tracked superinvestor, with a combined position value of $3 million . The largest positions are held by Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions.